Seung-Ho Choi Selected Research

Fluorine

1/2020	18F-FDG PET/CT versus CT/MR imaging for detection of neck lymph node metastasis in palpably node-negative oral cavity cancer.
1/2019	Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma.
12/2015	Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
3/2015	Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
12/2014	Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
8/2014	Clinical values for abnormal ¹⁸F-FDG uptake in the head and neck region of patients with head and neck squamous cell carcinoma.
4/2014	18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seung-Ho Choi Research Topics

Disease

73	Neoplasms (Cancer) 04/2024 - 04/2004
34	Squamous Cell Carcinoma of Head and Neck 01/2020 - 04/2005
24	Neoplasm Metastasis (Metastasis) 12/2020 - 02/2007
13	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 01/2008
12	Extranodal Extension 02/2024 - 04/2014
11	Carcinoma (Carcinomatosis) 01/2019 - 07/2006
8	Papillary Thyroid Cancer 02/2022 - 04/2014
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 05/2007
6	Lymphatic Metastasis 01/2020 - 09/2012
6	Hypoalbuminemia 12/2018 - 06/2011
5	Hypopharyngeal Neoplasms 01/2023 - 01/2012
5	Body Weight (Weight, Body) 01/2020 - 01/2013
4	Salivary Gland Neoplasms (Salivary Gland Cancer) 05/2015 - 02/2007
4	Hypoxia (Hypoxemia) 10/2012 - 06/2008
3	Deglutition Disorders (Dysphagia) 01/2023 - 01/2020
3	Paralysis (Palsy) 03/2022 - 04/2012
3	Margins of Excision 01/2020 - 01/2013
3	Second Primary Neoplasms (Neoplasms, Second) 02/2018 - 08/2014
3	Laryngeal Neoplasms (Laryngeal Cancer) 01/2017 - 06/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2016 - 01/2012
3	Tongue Neoplasms (Tongue Neoplasm) 01/2015 - 01/2009
3	Nasopharyngeal Carcinoma 05/2006 - 03/2005
2	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 04/2004
2	Pleomorphic Adenoma 05/2023 - 10/2011
2	Fistula 12/2022 - 01/2019
2	Vocal Cord Paralysis 09/2022 - 04/2012
2	Disease Progression 12/2018 - 10/2013
2	Infections 12/2018 - 01/2004
2	Adenoid Cystic Carcinoma (Cylindroma) 01/2018 - 10/2013
2	Necrosis 07/2017 - 01/2004
2	Adenocarcinoma 12/2016 - 06/2006
2	Pain (Aches) 12/2012 - 10/2010
2	Wounds and Injuries (Trauma) 06/2011 - 01/2004
1	Ranula 05/2024
1	Hoarseness 09/2022
1	Dyspnea (Shortness of Breath) 09/2022
1	Non-alcoholic Fatty Liver Disease 05/2022
1	Fatty Liver 05/2022
1	Aphonia 03/2022
1	Hypothyroidism 02/2022
1	Delirium 01/2022
1	Emergence Delirium 01/2022
1	Leukocytosis (Pleocytosis) 09/2019
1	Sarcopenia 01/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Hemorrhage 01/2019
1	Spasm (Spasms) 01/2019
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2018

Drug/Important Bio-Agent (IBA)

21	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 02/2007
14	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2008
7	FluorineIBA 01/2020 - 04/2014
7	Proteins (Proteins, Gene)FDA Link 12/2018 - 10/2011
5	Indicators and Reagents (Reagents)IBA 09/2017 - 02/2015
4	Serum AlbuminIBA 12/2018 - 02/2016
3	IodineIBA 10/2020 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 10/2011
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2012 - 01/2009
3	Erythropoietin Receptors (Erythropoietin Receptor)IBA 10/2012 - 06/2008
2	Thyroglobulin FDA Link 01/2019 - 08/2015
2	AlbuminsIBA 12/2018 - 12/2017
2	Hemoglobins (Hemoglobin)IBA 12/2017 - 02/2016
2	ErbB Receptors (EGF Receptor)IBA 07/2017 - 07/2008
2	Cisplatin (Platino)FDA LinkGeneric 03/2013 - 03/2005
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2012 - 04/2005
2	Carbonic Anhydrases (Carbonic Anhydrase)IBA 10/2012 - 01/2009
2	Monoclonal AntibodiesIBA 01/2009 - 06/2008
1	Ethanol (Ethyl Alcohol)IBA 05/2024
1	cyclo(Arg-Pro) (CI 4)IBA 05/2024
1	Androgen Receptors (Androgen Receptor)IBA 05/2023
1	human ERBB2 proteinIBA 05/2023
1	Thyroid HormonesIBA 02/2022
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 02/2022
1	Dexmedetomidine FDA Link 01/2019
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	Ephedrine FDA LinkGeneric 01/2019
1	Hormones (Hormone)IBA 12/2018

Therapy/Procedure

29	Radiotherapy 01/2022 - 03/2005
21	Neck Dissection (Radical Neck Dissection) 02/2024 - 05/2008
19	Therapeutics 02/2024 - 04/2004
13	Chemoradiotherapy 01/2020 - 09/2011
12	Aftercare (After-Treatment) 01/2023 - 02/2007
11	Thyroidectomy 09/2022 - 07/2007
6	Drug Therapy (Chemotherapy) 05/2016 - 06/2011
5	Tracheostomy 01/2022 - 01/2016
5	Salvage Therapy 09/2019 - 01/2016
4	Laryngectomy 01/2022 - 09/2015
4	Gastrectomy 01/2016 - 06/2006
2	Laryngoplasty 03/2022 - 04/2012
2	Early Ambulation 01/2022 - 12/2012
2	Blood Transfusion (Blood Transfusions) 03/2014 - 06/2011
2	Induction Chemotherapy 01/2012 - 09/2011
1	Enteral Nutrition (Feeding, Tube) 01/2023
1	Ligation 12/2022
1	Cautery 12/2022
1	Sutures (Suture) 12/2022
1	Gastrostomy 01/2022
1	Pharyngectomy 01/2022
1	Microvascular Decompression Surgery 01/2019
1	Debridement 12/2018